Terms: = Breast cancer AND SND1, Q7KZF4, TDRD11, p100, ENSG00000197157, 27044
49 results:
1. The chromatin architectural regulator snd1 mediates metastasis in triple-negative breast cancer by promoting CDH1 gene methylation.
Zhang H; Gao M; Zhao W; Yu L
Breast Cancer Res; 2023 Oct; 25(1):129. PubMed ID: 37885030
[TBL] [Abstract] [Full Text] [Related]
2. snd1, a novel co-activator of HIF1α, promotes tumor initiation in PyMT-induced breast tumor.
Hu L; Zeng Y; Xin L; Yang J
FEBS J; 2023 Dec; 290(24):5759-5772. PubMed ID: 37622244
[TBL] [Abstract] [Full Text] [Related]
3. Molecular Dynamics Simulation-Driven Focused Virtual Screening and Experimental Validation of Inhibitors for MTDH-snd1 Protein-Protein Interaction.
Xu Y; Guo X; Yan D; Dang X; Guo L; Jia T; Wang Q
J Chem Inf Model; 2023 Jun; 63(11):3614-3627. PubMed ID: 37226724
[TBL] [Abstract] [Full Text] [Related]
4. Molecular Design, Spectroscopic, DFT, Pharmacological, and Molecular Docking Studies of Novel Ruthenium(III)-Schiff Base Complex: An Inhibitor of Progression in HepG2 Cells.
Noureldeen AFH; Aziz SW; Shouman SA; Mohamed MM; Attia YM; Ramadan RM; Elhady MM
Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36294202
[TBL] [Abstract] [Full Text] [Related]
5. Structure-Based Design, Optimization, and Evaluation of Potent Stabilized Peptide Inhibitors Disrupting MTDH and snd1 Interaction.
Chen H; Zhan M; Liu J; Liu Z; Shen M; Yang F; Kang Y; Yin F; Li Z
J Med Chem; 2022 Sep; 65(18):12188-12199. PubMed ID: 36044768
[TBL] [Abstract] [Full Text] [Related]
6. Pharmacological disruption of the MTDH-snd1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer.
Shen M; Smith HA; Wei Y; Jiang YZ; Zhao S; Wang N; Rowicki M; Tang Y; Hang X; Wu S; Wan L; Shao ZM; Kang Y
Nat Cancer; 2022 Jan; 3(1):60-74. PubMed ID: 35121988
[TBL] [Abstract] [Full Text] [Related]
7. Small-molecule inhibitors that disrupt the MTDH-snd1 complex suppress breast cancer progression and metastasis.
Shen M; Wei Y; Kim H; Wan L; Jiang YZ; Hang X; Raba M; Remiszewski S; Rowicki M; Wu CG; Wu S; Zhang L; Lu X; Yuan M; Smith HA; Zheng A; Bertino J; Jin JF; Xing Y; Shao ZM; Kang Y
Nat Cancer; 2022 Jan; 3(1):43-59. PubMed ID: 35121987
[TBL] [Abstract] [Full Text] [Related]
8. HER2-PI9 and HER2-I12: two novel and functionally active splice variants of the oncogene HER2 in breast cancer.
Hart V; Silipo M; Satam S; Gautrey H; Kirby J; Tyson-Capper A
J Cancer Res Clin Oncol; 2021 Oct; 147(10):2893-2912. PubMed ID: 34136934
[TBL] [Abstract] [Full Text] [Related]
9. Disruption of snd1-MTDH Interaction by a High Affinity Peptide Results in snd1 Degradation and Cytotoxicity to breast cancer Cells
Li P; He Y; Chen T; Choy KY; Chow TS; Wong ILK; Yang X; Sun W; Su X; Chan TH; Chow LMC
Mol Cancer Ther; 2021 Jan; 20(1):76-84. PubMed ID: 33268570
[TBL] [Abstract] [Full Text] [Related]
10. A pan-cancer analysis of the oncogenic role of staphylococcal nuclease domain-containing protein 1 (snd1) in human tumors.
Cui X; Zhang X; Liu M; Zhao C; Zhang N; Ren Y; Su C; Zhang W; Sun X; He J; Gao X; Yang J
Genomics; 2020 Nov; 112(6):3958-3967. PubMed ID: 32645525
[TBL] [Abstract] [Full Text] [Related]
11. snd1 expression in breast cancer tumors is associated with poor prognosis.
Gu X; Xue J; Ai L; Sun L; Zhu X; Wang Y; Liu C
Ann N Y Acad Sci; 2018 Dec; 1433(1):53-60. PubMed ID: 30216461
[TBL] [Abstract] [Full Text] [Related]
12. Role of metadherin in estrogen-regulated gene expression.
Li Y; Gonzalez Bosquet J; Yang S; Thiel KW; Zhang Y; Liu H; Leslie KK; Meng X
Int J Mol Med; 2017 Aug; 40(2):303-310. PubMed ID: 28627585
[TBL] [Abstract] [Full Text] [Related]
13. Semi-automated De-identification of German Content Sensitive Reports for Big Data Analytics.
Seuss H; Dankerl P; Ihle M; Grandjean A; Hammon R; Kaestle N; Fasching PA; Maier C; Christoph J; Sedlmayr M; Uder M; Cavallaro A; Hammon M
Rofo; 2017 Jul; 189(7):661-671. PubMed ID: 28335044
[No Abstract] [Full Text] [Related]
14. snd1 acts as a novel gene transcription activator recognizing the conserved Motif domains of Smad promoters, inducing TGFβ1 response and breast cancer metastasis.
Yu L; Di Y; Xin L; Ren Y; Liu X; Sun X; Zhang W; Yao Z; Yang J
Oncogene; 2017 Jul; 36(27):3903-3914. PubMed ID: 28263968
[TBL] [Abstract] [Full Text] [Related]
15. Opposing roles of Nfkb2 gene products p100 and p52 in the regulation of breast cancer stem cells.
Yeo SK; French R; Spada F; Clarkson R
Breast Cancer Res Treat; 2017 Apr; 162(3):465-477. PubMed ID: 28190248
[TBL] [Abstract] [Full Text] [Related]
16. Low glucose dependent decrease of apoptosis and induction of autophagy in breast cancer MCF-7 cells.
Krętowski R; Borzym-Kluczyk M; Stypułkowska A; Brańska-Januszewska J; Ostrowska H; Cechowska-Pasko M
Mol Cell Biochem; 2016 Jun; 417(1-2):35-47. PubMed ID: 27160935
[TBL] [Abstract] [Full Text] [Related]
17. Inhibitory effect of miR-184 on the potential of proliferation and invasion in human glioma and breast cancer cells in vitro.
Feng R; Dong L
Int J Clin Exp Pathol; 2015; 8(8):9376-82. PubMed ID: 26464691
[TBL] [Abstract] [Full Text] [Related]
18. SRSF3 and hnRNP H1 regulate a splicing hotspot of HER2 in breast cancer cells.
Gautrey H; Jackson C; Dittrich AL; Browell D; Lennard T; Tyson-Capper A
RNA Biol; 2015; 12(10):1139-51. PubMed ID: 26367347
[TBL] [Abstract] [Full Text] [Related]
19. Electroretinographic and optical coherence tomography findings in breast cancer patients using aromatase inhibitors.
Moschos MM; Chatziralli IP; Sergentanis T; Zagouri F; Chrysikos D; Ladas I; Zografos G
Cutan Ocul Toxicol; 2016 Mar; 35(1):13-20. PubMed ID: 25597370
[TBL] [Abstract] [Full Text] [Related]
20. snd1 Acts Downstream of TGFβ1 and Upstream of Smurf1 to Promote breast cancer Metastasis.
Yu L; Liu X; Cui K; Di Y; Xin L; Sun X; Zhang W; Yang X; Wei M; Yao Z; Yang J
Cancer Res; 2015 Apr; 75(7):1275-86. PubMed ID: 25596283
[TBL] [Abstract] [Full Text] [Related]
[Next]
